Management, led by the MD, is responsible for the Fund’s daily operations concerning matters not reserved for the Board. We have established robust processes to ensure that authority is delegated from the Board and its committees to the MD and the Executive Committee (EXCO), facilitating decision-making throughout the organisation. At the same time, accountability is maintained through a feedback loop from the Fund to its members, strengthening alignment and open communication with all stakeholders.
The Board appoints the Fund's senior management and the Executive Committee and oversees succession planning for key management roles. In the past year, the Board approved the appointment of Gerald Paul Kasaato, previously the Chief Investment Officer (CIO), as the Deputy Managing Director, effective from 1 July 2024 and Kenneth Owera as the Acting CIO, effective from 1st July 2024. The Board also approved Mr. Dan Mugura as Head of Procurement Unit and Mrs. Peninnah Kabagambe Wabwire as Chief Enterprise and Growth Officer from 1 July 2024.
The Board also reviews the management team and succession plans to ensure that potential successors for critical positions, including the Managing Director and Deputy Managing Director, are identified and their performance assessed.
Dr David Ogong, an Independent Non-Executive Director, has been the Chairman since 1 September 2024, with his term set to end on 31 August 2027. The Chairman's responsibilities include:
Leading the Board to ensure it operates effectively and upholds high governance standards.
Fostering a culture of openness and discussion to create a high-performing and collaborative team.
Regularly reviewing and addressing strategic issues, member concerns, and stakeholder views.
Facilitating the relationship between the Board and the MD, providing oversight, guidance, and support.
Ensuring timely and quality information flows between the Board and management.
Setting meeting agendas that focus on the Fund’s strategic direction and performance.
Allowing sufficient time for discussions on all agenda items.
Leading performance assessments for the Board and individual Directors.
Representing the Board and advocating on its behalf to members.
The MD serves as the Chief Executive Officer of the Fund and operates under the NSSF Act (as amended), while also being accountable to the Board for matters of policy. The MD is responsible for overseeing the day-to-day operations, general management, administration, and organisation of the Fund, ensuring that the strategies and policies established by the Board are effectively implemented. Patrick Ayota, the MD, is the only Executive Director (ex officio member) on the Board and has been a member since December 2022.
The Corporation Secretary, Ms. Agnes Tibayeita Isharaza, has served in this capacity since her appointment on 1 April 2019. Her role, in accordance with Section 42 of the NSSF Act, is vital to the effective functioning of the Fund. Beyond any additional responsibilities assigned by the Minister and the Board, the Corporation Secretary safeguards the seal of the Fund and plays a key role in various important areas, including:
Ensures the seamless flow of crucial information within the Board, its committees, and between management and the Board itself.
Facilitating the orientation and ongoing professional development of Board members, helping them stay informed and engaged.
Records the minutes of Board meetings, as well as those of any committees and subcommittees, ensuring that all discussions and decisions are accurately captured.
Oversees the maintenance of all records related to the Fund's transactions, ensuring transparency and accountability
Offers legal advice on all Fund activities, helping to navigate the complexities of regulations and compliance.
Advises the Board on governance issues, promoting best practices and ethical standards.
Ensures that the Board is updated on relevant changes in legislation and corporate governance standards, enabling informed decision-making.